Letter: Why this medicine? Follow the money.
This Monday, April 6, 2020, photo shows an arrangement of hydroxychloroquine pills in Las Vegas. President Donald Trump and his administration kept up their out-sized promotion Monday of an malaria drug not yet officially approved for fighting the new coronavirus, even though scientists say more testing is needed before it’s proven safe and effective against COVID-19. Trump trade adviser Peter Navarro championed hydroxychloroquine in television interviews a day after the president publicly put his faith in the medication to lessen the toll of the coronavirus pandemic. (AP Photo/John Locher)
Joe Scarborough's advice on “Morning Joe” to just "follow the money" answers the question from Utah Senate President Stuart Adams and pharmacist Dan Richards about why President Trump has been touting hydroxychloroquine as a “game changer” in treating the coronavirus.
The New York Times reports the president’s family trusts all have investments in a mutual fund whose largest holding is Sanofi, the manufacturer of Plaquenil, the brand-name version of hydroxychloroquine. So do associates of the president, including Commerce Secretary Wilbur Ross.
Craige Mayeda, Bountiful
Submit a letter to the editor
Donate to the newsroom now. The Salt Lake Tribune, Inc. is a 501(c)(3) public charity and contributions are tax deductible